Importantly, mammary tumor progression of Shc1 deficient hyperplasias is significantly accelerated in athymic mice compared to immunocompetent animals, suggesting that Shc1 signaling suppresses T cell immune responses, ultimately facilitating tumor progression [85]. Here, SHC1 is linked to breast cancer.